RBX2660 for communicable diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Apr 2019: Trial registered, NCT03931941
  2. 30 Jul 2019: Trial started, NCT03931941

The trials

NCT03931941: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

State
Completed
Phase
Phase 3
People
793 taking part
Started
30 Jul 2019
Primary completion
21 Jul 2023
Arms
Active
Results
Posted on the registry
  1. 30 Apr 2019: Trial registered
  2. 30 Jul 2019: Trial started
  3. 21 Jul 2023: Trial completed
  4. 7 Aug 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.